Atrys Health, S.A. (BME:ATRY)

Spain flag Spain · Delayed Price · Currency is EUR
2.960
-0.020 (-0.68%)
Feb 27, 2026, 5:35 PM CET
-15.67%
Market Cap 224.59M
Revenue (ttm) 226.24M
Net Income (ttm) -24.59M
Shares Out 75.87M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE 32.67
Dividend n/a
Ex-Dividend Date n/a
Volume 49,200
Average Volume 42,496
Open 2.990
Previous Close 2.960
Day's Range 2.930 - 2.990
52-Week Range 2.480 - 3.590
Beta 0.61
RSI 45.92
Earnings Date Mar 27, 2026

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,016
Stock Exchange Madrid Stock Exchange
Ticker Symbol ATRY
Full Company Profile

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.

Financial Statements

News

There is no news available yet.